CClinicalTrials.gg
Enrolling by invitationNCT06758219Updated Apr 22, 2026

Validity and Reliability of the Turkish Form of the Knowledge Assessment Scales for Dementia and Urinary Incontinence

An observational study in Urinary Incontinence in Old Age and Dementia, sponsored by Kirsehir Ahi Evran Universitesi. Enrolling by invitation at 1 site in Turkey (Türkiye). Open to participants aged 55 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-22.

Sponsored by Kirsehir Ahi Evran Universitesi · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
230
Ages
55 Years to 70 Years
Sex
All
01

Study summary

The primary aim of the study was to determine the Turkish version of the "Validity and Reliability of the Knowledge Assessment Scales for Dementia and Urinary Incontinence in Community Older People". The secondary aim of the study was to measure the knowledge level of dementia and urinary incontinence in the community-living elderly population.

02

Conditions studied

  • Urinary Incontinence in Old Age
  • Dementia

Keywords

  • Urinary Incontinence
  • Dementia
  • Validity
  • Reliability
03

In context

Dementia

2,172 studies on the registry are indexed under Dementia; 540 are open to participants now.

This study's planned enrollment of 230 is close to the median of 250 across 482 observational studies indexed under Dementia.

Browse Dementia studies →

Lead sponsor

Kirsehir Ahi Evran Universitesi is the lead sponsor of 133 studies on the registry; 55 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
55 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

The study will be conducted at Kırşehir Ahi Evran University Physical Therapy and Rehabilitation Center. All patient relatives and hospital staff who meet the inclusion criteria will be included in the study. These participants will be reached through face-to-face communication or online methods (sms, e-mail), and a list of participants will be prepared and evaluations will be made.

Inclusion criteria

  1. Being 55 years of age or older
  2. Knowing how to read and write
  3. Being willing to participate in the study

Exclusion criteria

Exclusion Criteria:

1. Having any chronic illness that would prevent urinary retention and dementia level

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
230 participants (estimated)
Patient registry
No

Groups and cohorts

  • Study Group

    Other: There is no intervention in the study.

Interventions

  • OtherThere is no intervention in the study.

    There is no intervention in the study.

06

What researchers measure

Primary outcomes

  1. Knowledge Assessment Scales for Dementia and Urinary Incontinence in Community Older People

    The scale was developed by Hui Sun et al. to assess the level of knowledge about dementia and urinary incontinence among elderly individuals living in the community. The original language of the scale is Chinese and was translated into English by the researchers. The two knowledge assessment scales for dementia and urinary incontinence consist of 12 and 8 items, respectively. The model fit indicators of both met the criteria of confirmatory factor analysis. Cronbach'sα was 0.82 and 0.70, respectively. The completion rate and completion time of the two scales were 83.51% and 4.22±1.90 minutes.

    Time frame: 20 weeks

Secondary outcomes

  1. International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF)

    The severity of incontinence and its impact on the quality of life of the participants will be assessed with the ICIQ-SF. The ICIQ-SF consists of 6 items that question the type and frequency of urinary incontinence and the impact of incontinence on the individual's quality of life. The total score that can be obtained from the scale varies between 0-21. An increase in the total score indicates an increase in the severity of incontinence.

    Time frame: 20 weeks

  2. Incontinence Quality of Life Questionnaire (I-QOL)

    The participants' quality of life will be assessed with the I-QOL, which was specifically developed for urinary incontinence. The I-QOL is a scale consisting of 22 items and 3 subgroups that questions thoughts such as anxiety and depression that develop due to incontinence and the reflection of these thoughts on life. The total score that can be obtained from the scale varies between 0-100, and higher scores indicate better quality of life.

    Time frame: 20 weeks

  3. Standardize Mini Mental State (SMMS)

    SMMS will be used to assess the cognitive status of the participants. SMMS is a scale consisting of 11 items and 5 subgroups that measure cognitive functions. The total score that can be obtained from the scale varies between 0-30, and it is recommended that those who score 24 and below be evaluated for dementia.

    Time frame: 20 weeks

  4. Lawton-Brody Instrumental Activities of Daily Living Scale (IADL)

    The independence of the participants in their daily living activities will be assessed with the IADL. The IADL is a scale consisting of 8 items that assess instrumental daily living activities. The total score that can be obtained from the scale varies between 0-24, and an increase in the score indicates an increase in the level of independence.

    Time frame: 20 weeks

07

Study locations

1 site
  • Kirsehir Ahi Evran University Physical Therapy and Rehabilitation Center
    Kırşehir, Merkez 40100, Turkey (Türkiye)
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06758219
Lead sponsor
Kirsehir Ahi Evran Universitesi
Responsible party
Atahan TURHAN (Dr. Lecturer, Kirsehir Ahi Evran Universitesi) — Principal investigator
First posted
Jan 3, 2025
Start date
Dec 8, 2024
Primary completion
Jul 10, 2026 (estimated)
Completion
Aug 10, 2026 (estimated)
Last update
Apr 22, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion